about
Role of Receptor Tyrosine Kinase Signaling in Renal FibrosisA combination of low-dose bevacizumab and imatinib enhances vascular normalisation without inducing extracellular matrix deposition.Effect of bevacizumab on the expression of fibrosis-related inflammatory mediators in ARPE-19 cells.The relationship between anti-vascular endothelial growth factor and fibrosis in proliferative retinopathy: clinical and laboratory evidence.Endometriotic mesenchymal stem cells significantly promote fibrogenesis in ovarian endometrioma through the Wnt/β-catenin pathway by paracrine production of TGF-β1 and Wnt1.Rapid "epiretinal membrane" development following intravitreal bevacizumab for Coats' disease.Research progress on the role of connective tissue growth factor in fibrosis of diabetic retinopathy
P2860
Q26743407-23E68A53-D215-4EAA-A396-903B3344839BQ38718622-906B955B-7A93-4065-AF43-9A3170881560Q41808036-B0100E8F-5D77-4E8F-84DA-BA5EF9B49FE3Q51567551-C5029F9C-CF20-4A1F-92FA-9D54D3802174Q53139818-75A03914-C87B-463B-91FD-77A6C8F53791Q55389699-41F67021-CBD3-4568-AD50-A029F5527B07Q58728123-9ADB545B-F56D-4879-85A2-8C8156564479
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Bevacizumab modulates the process of fibrosis in vitro.
@en
Bevacizumab modulates the process of fibrosis in vitro.
@nl
type
label
Bevacizumab modulates the process of fibrosis in vitro.
@en
Bevacizumab modulates the process of fibrosis in vitro.
@nl
prefLabel
Bevacizumab modulates the process of fibrosis in vitro.
@en
Bevacizumab modulates the process of fibrosis in vitro.
@nl
P2093
P2860
P356
P1476
Bevacizumab modulates the process of fibrosis in vitro.
@en
P2093
Fanxing Zeng
Haifeng Xu
Sanjun Chu
P2860
P304
P356
10.1111/CEO.12374
P577
2014-08-19T00:00:00Z